Matches in SemOpenAlex for { <https://semopenalex.org/work/W4230429237> ?p ?o ?g. }
Showing items 1 to 60 of
60
with 100 items per page.
- W4230429237 endingPage "12" @default.
- W4230429237 startingPage "12" @default.
- W4230429237 abstract "Hashimoto's thyroiditis, which is characterized by anti-thyroid antibodies such as the anti-thyroglobulin (Tg) antibody and anti-thyroid peroxidase (TPO) antibody, is one of the autoimmune diseases associated with psychiatric illnesses. We previously reported a high prevalence of antibodies to N-terminals of N-methyl-D-aspartate (NMDA) type glutamate receptor (GluR) subunits (GluN1-NT and GluN2B-NT2) among psychiatric patients with anti-thyroid antibodies. However, it remains unclear whether the presence of anti-thyroid antibodies influences antibodies to GluN1-NT or GluN2B-NT2 among psychiatric patients. The present study aims to examine antibodies to GluN1-NT and GluN2B-NT2 in psychiatric patients with anti-thyroid antibodies (PPATs) and in those without (non-PPATs).We recruited psychiatric inpatients aged 20–60 years. Patients were excluded if they had a history of neurological diseases, dementia, developmental disorders, tumors, or autoimmune diseases except autoimmune thyroiditis. The rest of the participants were divided into two groups according to the presence of serum anti-Tg and anti-TPO antibodies. We investigated serum and cerebrospinal fluid (CSF) antibodies to GluN1-NT and GluN2B-NT2 using an enzyme-linked immunosorbent assay (ELISA).We initially recruited seventy-three psychiatric inpatients. Forty-six patients were excluded because of the exclusion criteria. Eighteen PPATs and nine non-PPATs were ultimately enrolled. We also collected stored sera of eighteen healthy controls (HCs) who were age- and sex-matched with PPATs. The optical densities (ODs) of serum antibodies to GluN1-NT (p = 0.0020) and GluN2B-NT2 (p = 0.039) were significantly higher in PPATs than in HCs. The ODs of CSF antibodies to GluN1-NT (p = 0.030) and GluN2B-NT2 (p = 0.017) as well as the positive ratios of those antibodies were significantly higher in PPATs than in non-PPATs.Our finding indicates that detecting anti-thyroid antibodies in psychiatric patients would be a clue to consider psychiatric conditions related to antibodies to GluN1-NT/GluN2B-NT2. Further studies focusing on the relationship between PPATs and antibodies to GluN1-NT/GluN2B-NT2 are needed." @default.
- W4230429237 created "2022-05-11" @default.
- W4230429237 date "2020-10-01" @default.
- W4230429237 modified "2023-09-30" @default.
- W4230429237 title "Diary" @default.
- W4230429237 doi "https://doi.org/10.1016/s1359-6128(20)30299-8" @default.
- W4230429237 hasPublicationYear "2020" @default.
- W4230429237 type Work @default.
- W4230429237 citedByCount "0" @default.
- W4230429237 crossrefType "journal-article" @default.
- W4230429237 hasConcept C126322002 @default.
- W4230429237 hasConcept C134018914 @default.
- W4230429237 hasConcept C159654299 @default.
- W4230429237 hasConcept C163764329 @default.
- W4230429237 hasConcept C180650514 @default.
- W4230429237 hasConcept C203014093 @default.
- W4230429237 hasConcept C2776362883 @default.
- W4230429237 hasConcept C2778696486 @default.
- W4230429237 hasConcept C2778835679 @default.
- W4230429237 hasConcept C2779134260 @default.
- W4230429237 hasConcept C2779483572 @default.
- W4230429237 hasConcept C50181227 @default.
- W4230429237 hasConcept C526584372 @default.
- W4230429237 hasConcept C71924100 @default.
- W4230429237 hasConcept C90924648 @default.
- W4230429237 hasConceptScore W4230429237C126322002 @default.
- W4230429237 hasConceptScore W4230429237C134018914 @default.
- W4230429237 hasConceptScore W4230429237C159654299 @default.
- W4230429237 hasConceptScore W4230429237C163764329 @default.
- W4230429237 hasConceptScore W4230429237C180650514 @default.
- W4230429237 hasConceptScore W4230429237C203014093 @default.
- W4230429237 hasConceptScore W4230429237C2776362883 @default.
- W4230429237 hasConceptScore W4230429237C2778696486 @default.
- W4230429237 hasConceptScore W4230429237C2778835679 @default.
- W4230429237 hasConceptScore W4230429237C2779134260 @default.
- W4230429237 hasConceptScore W4230429237C2779483572 @default.
- W4230429237 hasConceptScore W4230429237C50181227 @default.
- W4230429237 hasConceptScore W4230429237C526584372 @default.
- W4230429237 hasConceptScore W4230429237C71924100 @default.
- W4230429237 hasConceptScore W4230429237C90924648 @default.
- W4230429237 hasIssue "10" @default.
- W4230429237 hasLocation W42304292371 @default.
- W4230429237 hasOpenAccess W4230429237 @default.
- W4230429237 hasPrimaryLocation W42304292371 @default.
- W4230429237 hasRelatedWork W161873529 @default.
- W4230429237 hasRelatedWork W1966161148 @default.
- W4230429237 hasRelatedWork W2013347057 @default.
- W4230429237 hasRelatedWork W2023961065 @default.
- W4230429237 hasRelatedWork W2125320223 @default.
- W4230429237 hasRelatedWork W2152685219 @default.
- W4230429237 hasRelatedWork W2171427547 @default.
- W4230429237 hasRelatedWork W2977983252 @default.
- W4230429237 hasRelatedWork W4300523930 @default.
- W4230429237 hasRelatedWork W2407057245 @default.
- W4230429237 hasVolume "2020" @default.
- W4230429237 isParatext "false" @default.
- W4230429237 isRetracted "false" @default.
- W4230429237 workType "article" @default.